MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$2,082K
Net Income
-$30,199K
Net Profit Margin
-1450.48%
EPS
-$0.25
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Collaboration revenue
2,082
1,299
1,591*
1,741
Research and development
24,387
24,703
25,368*
25,838
General and administrative
8,829
9,596
9,905*
10,638
Impairment loss
-
-
0*
-
Total operating expenses
33,216
34,299
35,272*
36,476
Loss from operations
-31,134
-33,000
-33,681*
-34,735
Interest income
1,555
1,867
2,186*
2,575
Change in fair value of stock price appreciation milestones
580
80
41*
90
Other income
0
0
29*
0
Total other income
975
1,787
2,173*
2,485
Net loss
-30,159
-31,213
-31,508*
-32,250
Unrealized loss on available-for-sale securities, net
-40
-193
-173*
91
Comprehensive loss
-30,199
-31,406
-31,681
-32,159
Basic EPS
-0.25
-0.26
-0.266
-0.27
Diluted EPS
-0.25
-0.26
-0.266
-0.27
Basic Average Shares
120,397,390
120,030,638
118,995,689
118,998,693
Diluted Average Shares
120,397,390
120,030,638
118,995,689
118,998,693
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Comprehensive loss
-$30,199K
Interest income
$1,555K
Net loss
-$30,159K
Unrealized loss on
available-for-sale securities, net
-$40K
Total other income
$975K
Change in fair value of
stock price...
$580K
Loss from operations
-$31,134K
Collaboration revenue
$2,082K
Total operating
expenses
$33,216K
Research and development
$24,387K
General and
administrative
$8,829K
Buy us a coffee
FATE THERAPEUTICS INC (FATE)
FATE THERAPEUTICS INC (FATE)